Sparta Cancer Center has recently received Thomas Jefferson University Hospital’s Recognition Award for Outstanding Patient Accrual in Clinical Trials. Jefferson’s Kimmel Cancer Center, a National Cancer Institute (NCI) designated center, is home to internationally renowned cancer physicians and research scientists. Sparta Cancer Center physicians collaborate with physicians at the Kimmel Cancer Center Network for clinical research through RTOG (Radiation Therapy Oncology Group).
Funded by NCI and composed of 250 major research groups such as Sparta Cancer Center, RTOG has been the leader in radiation therapy cancer research for 30 years in the United States and Canada.
Sparta Cancer Center’s Dr. Michael Gallagher and his partners have participated in RTOG research studies for over 20 years. Offering the latest technological advances in therapy translates to cancer patients and their families benefiting from the most advanced treatment and research opportunities without having to travel long distances. Cancer treatment facilities that offer such NCI-sponsored research must meet very high standards not demanded in non-participating institutions.
Clinical trials are available for most types and stages of cancer. The doctors at Sparta Cancer Center determine whether patients are eligible to participate in these clinical research trials. For eligible patients, the decision to participate in a trial ultimately rests with them. Patients participate only after they have received comprehensive information about the trial and have voluntarily decided to be part of the study that is applicable to their case.
Sparta Cancer Center is a joint venture between the physicians (Sussex Radiation Oncology Associates) and Newton Memorial Hospital. The Center has been a member of the Jefferson Kimmel Cancer Center Network, Philadelphia, since 2006.
Pictured with the award are Tom Senker, CEO and President, Newton Memorial Hospital; Megan Frugone, RN, and Christine L. Lyasko, RN, Clinical Research Associates; and Sean O’Rourke, COO and Senior VP, Newton Memorial Hospital.
About Cancer Research:
The team of physicians at Sparta
Cancer Center is dedicated to
providing the most advanced treatment and the highest standards
of care. One way we do this is by offering cancer patients
the opportunity to participate in
cancer clinical research trials sponsored by the National Cancer
Institute (NCI). These trials are available through our
tri-state network of cancer centers, so patients do not have to travel long distances to
benefit from state-of-the-science cancer therapies.
Cancer clinical trials are research studies conducted with patients to evaluate
new treatments. Each study is designed to answer specific medical
questions and to find new and better ways to help people with cancer.
Research trials sponsored by NCI are offered to patients only by experienced
physicians in accredited facilities such as ours. People decide to enroll in a
clinical trial only after they have discussed the study thoroughly with their
physician and they have made an informed decision to participate.
treatment studies, scientists seek to determine if new treatments are safe,
effective, and superior to standard treatments. These cancer studies look at
many types of treatments, such as new drugs or vaccines, new approaches to
surgery, radiation therapy or chemotherapy, or new combinations of these
studies seek to improve the quality of life for cancer patients. Or, they may
seek to find the most effective way to prevent a recurrence of cancer after
treatments currently available for patients often are the result of earlier
clinical trials. In turn, today’s standard treatments may be the basis for new
clinical trials to find better ways to treat cancer.
other research studies, known as prevention trials, look at ways to prevent
The doctors at Sparta Cancer
Center are accredited by the National Cancer Institute (NCI) to participate in cancer research trials. This means they have access to the newest, most advanced treatment protocols available in the country for cancer treatment.
Cancer treatment facilities that offer such state-of-the-art NCI-sponsored research must meet very high standards not demanded in non-participating institutions.
Patients who wish to benefit from these cancer clinical trials may do so only in cancer centers such as
ours that are accredited by the National Cancer Institute.
Our physicians have participated as Principal
Investigators in cancer research trials for over 20 years through the Radiation Therapy Oncology Group (RTOG), sponsored by the National Cancer Institute.
Our research team has been recognized nationally for the outstanding quality of its research, and hundreds of patients have participated and benefited from these research studies.
Clinical trials are available for most types and stages of cancer. The doctors determine whether patients are eligible to participate in these clinical research trials.
For eligible patients, the decision to participate in a trial ultimately rests with them. Patients participate only after they have received comprehensive information about the trial and have voluntarily decided to be part of the study that is applicable to their case.
Many of the cancer trials available through
Sparta Cancer Center are offered through the Radiation Therapy Oncology Group (RTOG).
Our physicians have participated in RTOG research studies for nearly 20 years.
RTOG is a multi-institutional cooperative cancer research organization funded by the National Cancer Institute (NCI). RTOG, which is composed of 250 major research groups such as
ours, has been the leader in radiation therapy cancer research for 30 years in the United States and Canada. Click here for more information about RTOG.
Our physicians also collaborate with physicians at the Thomas Jefferson University Hospital Cancer Network for RTOG research. For more information about the radiation therapy clinical trials available through the Jefferson Cancer Network,